{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-26-053378","form_type":"8-K","ticker":"CNTX","cik":"0001842952","company_name":"Context Therapeutics Inc.","filed_at":"2026-08-05T20:16:31+00:00","discovered_at":"2026-08-05T20:18:10.249664+00:00","generated_at":"2026-08-05T20:18:46.634882+00:00","sec_items":["7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"low","headline":"Context Therapeutics updates corporate presentation for investor meetings; no specific new data disclosed","bullets":["Filed an 8-K on August 5, 2026, to furnish an updated corporate presentation as Exhibit 99.1.","Presentation titled 'Advancing T Cell Engagers for Solid Tumors' but full content not provided in filing.","No financial results, clinical data, or material events announced in the 8-K body.","Routine FD disclosure; presentation used for meetings with investors and analysts."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-053378","json":"https://secwatch.observer/filing/0001628280-26-053378.json","markdown":"https://secwatch.observer/filing/0001628280-26-053378.md","text":"https://secwatch.observer/filing/0001628280-26-053378.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1842952/000162828026053378/0001628280-26-053378-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1842952/000162828026053378/cntx-20260805.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-05T20:18:46.634882+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}